APO Research
Talk to an analyst

APO RESEARCH · REPORT

β-Nicotinamide Mononucleotide (NMN)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global β-Nicotinamide Mononucleotide (NMN) Market Analysis and Forecast 2026-2032

22 December 2025207 pages

Choose your research edition.

Industry Researchβ-Nicotinamide Mononucleotide (NMN) Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal β-Nicotinamide Mononucleotide (NMN) Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal β-Nicotinamide Mononucleotide (NMN) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal β-Nicotinamide Mononucleotide (NMN) Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal β-Nicotinamide Mononucleotide (NMN) Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global β-Nicotinamide Mononucleotide (NMN) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

β-Nicotinamide Mononucleotide (NMN)'s global sales reached XX (Kg) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned GeneHarbor as the global sales leader, a title it has maintained for several consecutive years. Notably, GeneHarbor's performance in primary markets is also remarkable. In the Chinese market, sales were XX (Kg), a change of XX% from the previous year. In Europe, sales were XX (Kg), showing a year-on-year of XX%. In the US, sales were XX (Kg), a year-on-year change of XX%.

The major global manufacturers in the β-Nicotinamide Mononucleotide (NMN) market include GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical, Maac10 Formulas, EffePharm, Bontac, CELFULL and Kingdomway, etc. In 2025, the top three vendors accounted for approximately % of the revenue.

Read the full market overview

In terms of production side, this report researches the β-Nicotinamide Mononucleotide (NMN) production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.

In terms of consumption side, this report focuses on the sales of β-Nicotinamide Mononucleotide (NMN) by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.

This report presents an overview of global market for β-Nicotinamide Mononucleotide (NMN), capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of β-Nicotinamide Mononucleotide (NMN), also provides the consumption of main regions and countries. Of the upcoming market potential for β-Nicotinamide Mononucleotide (NMN), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the β-Nicotinamide Mononucleotide (NMN) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global β-Nicotinamide Mononucleotide (NMN) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for β-Nicotinamide Mononucleotide (NMN) sales, projected growth trends, production technology, application and end-user industry.

β-Nicotinamide Mononucleotide (NMN) Segment by Company

GeneHarbor

Herbalmax

Genex Formulas

Shinkowa Pharmaceutical

Maac10 Formulas

EffePharm

Bontac

CELFULL

Kingdomway

β-Nicotinamide Mononucleotide (NMN) Segment by Content

Above 98%

Below 98%

β-Nicotinamide Mononucleotide (NMN) Segment by Application

Health Care Products

Cosmetics

Others

β-Nicotinamide Mononucleotide (NMN) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global β-Nicotinamide Mononucleotide (NMN) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of β-Nicotinamide Mononucleotide (NMN) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of β-Nicotinamide Mononucleotide (NMN).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: β-Nicotinamide Mononucleotide (NMN) production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Sales (consumption), revenue of β-Nicotinamide Mononucleotide (NMN) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 5: Detailed analysis of β-Nicotinamide Mononucleotide (NMN) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, β-Nicotinamide Mononucleotide (NMN) sales, revenue, price, gross margin, and recent development, etc.

Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 11: China by type, by application, sales, and revenue for each segment.

Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global β-Nicotinamide Mononucleotide (NMN) Market Size Growth Rate by Content (US$ Million), 2021 VS 2025 VS 2032 Table 2. Above 98% Major Manufacturers Table 3. Below 98% Major Manufacturers Table 4. Global β-Nicotinamide Mononucleotide (NMN) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Health Care Products Major Manufacturers Table 6. Cosmetics Major Manufacturers Table 7. Others Major Manufacturers Table 8. β-Nicotinamide Mononucleotide (NMN) Industry Trends Table 9. β-Nicotinamide Mononucleotide (NMN) Industry Drivers Table 10. β-Nicotinamide Mononucleotide (NMN) Industry Opportunities and Challenges Table 11. β-Nicotinamide Mononucleotide (NMN) Industry Restraints Table 12. Global β-Nicotinamide Mononucleotide (NMN) Production Growth Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Kg) Table 13. Global β-Nicotinamide Mononucleotide (NMN) Production by Region (2021-2026) & (Kg) Table 14. Global β-Nicotinamide Mononucleotide (NMN) Production by Region (2027-2032) & (Kg) Table 15. Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Region (2021-2026) Table 16. Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Region (2027-2032) Table 17. Global β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2021-2026) & (US$ Million) Table 19. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2027-2032) & (US$ Million) Table 20. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2021-2026) Table 21. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2027-2032) Table 22. Global β-Nicotinamide Mononucleotide (NMN) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Kg) Table 23. Global β-Nicotinamide Mononucleotide (NMN) Sales by Region (2021-2026) & (Kg) Table 24. Global β-Nicotinamide Mononucleotide (NMN) Sales by Region (2027-2032) & (Kg) Table 25. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2021-2026) Table 26. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2027-2032) Table 27. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Manufacturers (2021-2026) Table 29. Global β-Nicotinamide Mononucleotide (NMN) Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Manufacturers (2021-2026) Table 31. Global β-Nicotinamide Mononucleotide (NMN) Sales Price (US$/Kg) of Manufacturers (2021-2026) Table 32. Global β-Nicotinamide Mononucleotide (NMN) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global β-Nicotinamide Mononucleotide (NMN) Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global β-Nicotinamide Mononucleotide (NMN) Manufacturers, Product Type & Application Table 35. Global β-Nicotinamide Mononucleotide (NMN) Manufacturers Commercialization Time Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global β-Nicotinamide Mononucleotide (NMN) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 38. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2021-2026) & (US$ Million) Table 39. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2027-2032) & (US$ Million) Table 40. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Content (2021-2026) Table 41. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Content (2027-2032) Table 42. Global β-Nicotinamide Mononucleotide (NMN) Sales by Content (2021-2026) & (Kg) Table 43. Global β-Nicotinamide Mononucleotide (NMN) Sales by Content (2027-2032) & (Kg) Table 44. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Content (2021-2026) Table 45. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Content (2027-2032) Table 46. Global β-Nicotinamide Mononucleotide (NMN) Price by Content (2021-2026) & (US$/Kg) Table 47. Global β-Nicotinamide Mononucleotide (NMN) Price by Content (2027-2032) & (US$/Kg) Table 48. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2026) & (US$ Million) Table 49. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2027-2032) & (US$ Million) Table 50. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2021-2026) Table 51. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2027-2032) Table 52. Global β-Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026) & (Kg) Table 53. Global β-Nicotinamide Mononucleotide (NMN) Sales by Application (2027-2032) & (Kg) Table 54. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2021-2026) Table 55. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2027-2032) Table 56. Global β-Nicotinamide Mononucleotide (NMN) Price by Application (2021-2026) & (US$/Kg) Table 57. Global β-Nicotinamide Mononucleotide (NMN) Price by Application (2027-2032) & (US$/Kg) Table 58. GeneHarbor Company Information Table 59. GeneHarbor Business Overview Table 60. GeneHarbor β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 61. GeneHarbor β-Nicotinamide Mononucleotide (NMN) Product Portfolio Table 62. GeneHarbor Recent Development Table 63. Herbalmax Company Information Table 64. Herbalmax Business Overview Table 65. Herbalmax β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 66. Herbalmax β-Nicotinamide Mononucleotide (NMN) Product Portfolio Table 67. Herbalmax Recent Development Table 68. Genex Formulas Company Information Table 69. Genex Formulas Business Overview Table 70. Genex Formulas β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 71. Genex Formulas β-Nicotinamide Mononucleotide (NMN) Product Portfolio Table 72. Genex Formulas Recent Development Table 73. Shinkowa Pharmaceutical Company Information Table 74. Shinkowa Pharmaceutical Business Overview Table 75. Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 76. Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Product Portfolio Table 77. Shinkowa Pharmaceutical Recent Development Table 78. Maac10 Formulas Company Information Table 79. Maac10 Formulas Business Overview Table 80. Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 81. Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Product Portfolio Table 82. Maac10 Formulas Recent Development Table 83. EffePharm Company Information Table 84. EffePharm Business Overview Table 85. EffePharm β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 86. EffePharm β-Nicotinamide Mononucleotide (NMN) Product Portfolio Table 87. EffePharm Recent Development Table 88. Bontac Company Information Table 89. Bontac Business Overview Table 90. Bontac β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 91. Bontac β-Nicotinamide Mononucleotide (NMN) Product Portfolio Table 92. Bontac Recent Development Table 93. CELFULL Company Information Table 94. CELFULL Business Overview Table 95. CELFULL β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 96. CELFULL β-Nicotinamide Mononucleotide (NMN) Product Portfolio Table 97. CELFULL Recent Development Table 98. Kingdomway Company Information Table 99. Kingdomway Business Overview Table 100. Kingdomway β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 101. Kingdomway β-Nicotinamide Mononucleotide (NMN) Product Portfolio Table 102. Kingdomway Recent Development Table 103. North America β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2021-2026) & (US$ Million) Table 104. North America β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2027-2032) & (US$ Million) Table 105. North America β-Nicotinamide Mononucleotide (NMN) Sales by Content (2021-2026) & (Kg) Table 106. North America β-Nicotinamide Mononucleotide (NMN) Sales by Content (2027-2032) & (Kg) Table 107. North America β-Nicotinamide Mononucleotide (NMN) Sales Price by Content (2021-2026) & (US$/Kg) Table 108. North America β-Nicotinamide Mononucleotide (NMN) Sales Price by Content (2027-2032) & (US$/Kg) Table 109. North America β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2026) & (US$ Million) Table 110. North America β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2027-2032) & (US$ Million) Table 111. North America β-Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026) & (Kg) Table 112. North America β-Nicotinamide Mononucleotide (NMN) Sales by Application (2027-2032) & (Kg) Table 113. North America β-Nicotinamide Mononucleotide (NMN) Sales Price by Application (2021-2026) & (US$/Kg) Table 114. North America β-Nicotinamide Mononucleotide (NMN) Sales Price by Application (2027-2032) & (US$/Kg) Table 115. North America β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. North America β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 117. North America β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 118. North America β-Nicotinamide Mononucleotide (NMN) Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 119. North America β-Nicotinamide Mononucleotide (NMN) Sales by Country (2021-2026) & (Kg) Table 120. North America β-Nicotinamide Mononucleotide (NMN) Sales by Country (2027-2032) & (Kg) Table 121. North America β-Nicotinamide Mononucleotide (NMN) Sales Price by Country (2021-2026) & (US$/Kg) Table 122. North America β-Nicotinamide Mononucleotide (NMN) Sales Price by Country (2027-2032) & (US$/Kg) Table 123. United States β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 124. Canada β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 125. Mexico β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 126. Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2021-2026) & (US$ Million) Table 127. Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2027-2032) & (US$ Million) Table 128. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Content (2021-2026) & (Kg) Table 129. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Content (2027-2032) & (Kg) Table 130. Europe β-Nicotinamide Mononucleotide (NMN) Sales Price by Content (2021-2026) & (US$/Kg) Table 131. Europe β-Nicotinamide Mononucleotide (NMN) Sales Price by Content (2027-2032) & (US$/Kg) Table 132. Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2026) & (US$ Million) Table 133. Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2027-2032) & (US$ Million) Table 134. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026) & (Kg) Table 135. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Application (2027-2032) & (Kg) Table 136. Europe β-Nicotinamide Mononucleotide (NMN) Sales Price by Application (2021-2026) & (US$/Kg) Table 137. Europe β-Nicotinamide Mononucleotide (NMN) Sales Price by Application (2027-2032) & (US$/Kg) Table 138. Europe β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Europe β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 140. Europe β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 141. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 142. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Country (2021-2026) & (Kg) Table 143. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Country (2027-2032) & (Kg) Table 144. Europe β-Nicotinamide Mononucleotide (NMN) Sales Price by Country (2021-2026) & (US$/Kg) Table 145. Europe β-Nicotinamide Mononucleotide (NMN) Sales Price by Country (2027-2032) & (US$/Kg) Table 146. Germany β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 147. France β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 148. U.K. β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 149. Italy β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 150. Russia β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 151. Spain β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 152. Netherlands β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 153. Switzerland β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 154. Sweden β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 155. Poland β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 156. China β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2021-2026) & (US$ Million) Table 157. China β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2027-2032) & (US$ Million) Table 158. China β-Nicotinamide Mononucleotide (NMN) Sales by Content (2021-2026) & (Kg) Table 159. China β-Nicotinamide Mononucleotide (NMN) Sales by Content (2027-2032) & (Kg) Table 160. China β-Nicotinamide Mononucleotide (NMN) Sales Price by Content (2021-2026) & (US$/Kg) Table 161. China β-Nicotinamide Mononucleotide (NMN) Sales Price by Content (2027-2032) & (US$/Kg) Table 162. China β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2026) & (US$ Million) Table 163. China β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2027-2032) & (US$ Million) Table 164. China β-Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026) & (Kg) Table 165. China β-Nicotinamide Mononucleotide (NMN) Sales by Application (2027-2032) & (Kg) Table 166. China β-Nicotinamide Mononucleotide (NMN) Sales Price by Application (2021-2026) & (US$/Kg) Table 167. China β-Nicotinamide Mononucleotide (NMN) Sales Price by Application (2027-2032) & (US$/Kg) Table 168. Asia β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2021-2026) & (US$ Million) Table 169. Asia β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2027-2032) & (US$ Million) Table 170. Asia β-Nicotinamide Mononucleotide (NMN) Sales by Content (2021-2026) & (Kg) Table 171. Asia β-Nicotinamide Mononucleotide (NMN) Sales by Content (2027-2032) & (Kg) Table 172. Asia β-Nicotinamide Mononucleotide (NMN) Sales Price by Content (2021-2026) & (US$/Kg) Table 173. Asia β-Nicotinamide Mononucleotide (NMN) Sales Price by Content (2027-2032) & (US$/Kg) Table 174. Asia β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2026) & (US$ Million) Table 175. Asia β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2027-2032) & (US$ Million) Table 176. Asia β-Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026) & (Kg) Table 177. Asia β-Nicotinamide Mononucleotide (NMN) Sales by Application (2027-2032) & (Kg) Table 178. Asia β-Nicotinamide Mononucleotide (NMN) Sales Price by Application (2021-2026) & (US$/Kg) Table 179. Asia β-Nicotinamide Mononucleotide (NMN) Sales Price by Application (2027-2032) & (US$/Kg) Table 180. Asia β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 181. Asia β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 182. Asia β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 183. Asia β-Nicotinamide Mononucleotide (NMN) Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 184. Asia β-Nicotinamide Mononucleotide (NMN) Sales by Country (2021-2026) & (Kg) Table 185. Asia β-Nicotinamide Mononucleotide (NMN) Sales by Country (2027-2032) & (Kg) Table 186. Asia β-Nicotinamide Mononucleotide (NMN) Sales Price by Country (2021-2026) & (US$/Kg) Table 187. Asia β-Nicotinamide Mononucleotide (NMN) Sales Price by Country (2027-2032) & (US$/Kg) Table 188. Japan β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 189. South Korea β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 190. India β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 191. Australia β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 192. Taiwan β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 193. Southeast Asia β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 194. SAMEA β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2021-2026) & (US$ Million) Table 195. SAMEA β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2027-2032) & (US$ Million) Table 196. SAMEA β-Nicotinamide Mononucleotide (NMN) Sales by Content (2021-2026) & (Kg) Table 197. SAMEA β-Nicotinamide Mononucleotide (NMN) Sales by Content (2027-2032) & (Kg) Table 198. SAMEA β-Nicotinamide Mononucleotide (NMN) Sales Price by Content (2021-2026) & (US$/Kg) Table 199. SAMEA β-Nicotinamide Mononucleotide (NMN) Sales Price by Content (2027-2032) & (US$/Kg) Table 200. SAMEA β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2026) & (US$ Million) Table 201. SAMEA β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2027-2032) & (US$ Million) Table 202. SAMEA β-Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026) & (Kg) Table 203. SAMEA β-Nicotinamide Mononucleotide (NMN) Sales by Application (2027-2032) & (Kg) Table 204. SAMEA β-Nicotinamide Mononucleotide (NMN) Sales Price by Application (2021-2026) & (US$/Kg) Table 205. SAMEA β-Nicotinamide Mononucleotide (NMN) Sales Price by Application (2027-2032) & (US$/Kg) Table 206. SAMEA β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 207. SAMEA β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 208. SAMEA β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 209. SAMEA β-Nicotinamide Mononucleotide (NMN) Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 210. SAMEA β-Nicotinamide Mononucleotide (NMN) Sales by Country (2021-2026) & (Kg) Table 211. SAMEA β-Nicotinamide Mononucleotide (NMN) Sales by Country (2027-2032) & (Kg) Table 212. SAMEA β-Nicotinamide Mononucleotide (NMN) Sales Price by Country (2021-2026) & (US$/Kg) Table 213. SAMEA β-Nicotinamide Mononucleotide (NMN) Sales Price by Country (2027-2032) & (US$/Kg) Table 214. Brazil β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 215. Argentina β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 216. Chile β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 217. Colombia β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 218. Peru β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 219. Saudi Arabia β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 220. Israel β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 221. UAE β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 222. Turkey β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 223. Iran β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 224. Egypt β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 225. Key Raw Materials Table 226. Raw Materials Key Suppliers Table 227. β-Nicotinamide Mononucleotide (NMN) Distributors List Table 228. β-Nicotinamide Mononucleotide (NMN) Customers List Table 229. Research Programs/Design for This Report Table 230. Authors List of This Report Table 231. Secondary Sources Table 232. Primary Sources List of Figures Figure 1. β-Nicotinamide Mononucleotide (NMN) Product Image Figure 2. Global β-Nicotinamide Mononucleotide (NMN) Market Size Growth Rate by Content (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global β-Nicotinamide Mononucleotide (NMN) Market Size Share 2021 VS 2025 VS 2032 Figure . Above 98% Image Figure 1. Below 98% Image Figure 2. Global β-Nicotinamide Mononucleotide (NMN) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global β-Nicotinamide Mononucleotide (NMN) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Health Care Products Image Figure 5. Cosmetics Image Figure 6. Others Image Figure 7. Global β-Nicotinamide Mononucleotide (NMN) Capacity, Capacity Utilization (2021-2032) & (Kg) Figure 8. Global β-Nicotinamide Mononucleotide (NMN) Production by Region: 2021 VS 2025 VS 2032 (Kg) Figure 9. Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Region: 2025 Versus 2032 Figure 10. Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Region (2021-2032) Figure 11. North America β-Nicotinamide Mononucleotide (NMN) Production Growth Rate (2021-2032) & (Kg) Figure 12. Europe β-Nicotinamide Mononucleotide (NMN) Production Growth Rate (2021-2032) & (Kg) Figure 13. China β-Nicotinamide Mononucleotide (NMN) Production Growth Rate (2021-2032) & (Kg) Figure 14. Japan β-Nicotinamide Mononucleotide (NMN) Production Growth Rate (2021-2032) & (Kg) Figure 15. Global β-Nicotinamide Mononucleotide (NMN) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Figure 17. Global β-Nicotinamide Mononucleotide (NMN) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2021-2032) Figure 20. Global β-Nicotinamide Mononucleotide (NMN) Sales (2021-2032) & (Kg) Figure 21. Global β-Nicotinamide Mononucleotide (NMN) Sales by Region: 2021 VS 2025 VS 2032 (Kg) Figure 22. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2021-2032) Figure 23. North America β-Nicotinamide Mononucleotide (NMN) Sales YoY (2021-2032) & (Kg) Figure 24. Europe β-Nicotinamide Mononucleotide (NMN) Sales YoY (2021-2032) & (Kg) Figure 25. China β-Nicotinamide Mononucleotide (NMN) Sales YoY (2021-2032) & (Kg) Figure 26. Asia (Excluding China) β-Nicotinamide Mononucleotide (NMN) Sales YoY (2021-2032) & (Kg) Figure 27. South America, Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Sales YoY (2021-2032) & (Kg) Figure 28. Global β-Nicotinamide Mononucleotide (NMN) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global β-Nicotinamide Mononucleotide (NMN) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Content (2021-2032) Figure 32. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Content (2021-2032) Figure 33. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2021-2032) Figure 34. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2021-2032) Figure 35. North America β-Nicotinamide Mononucleotide (NMN) Revenue Share by Content (2021-2032) Figure 36. North America β-Nicotinamide Mononucleotide (NMN) Sales Share by Content (2021-2032) Figure 37. North America β-Nicotinamide Mononucleotide (NMN) Revenue Share by Application (2021-2032) Figure 38. North America β-Nicotinamide Mononucleotide (NMN) Sales Share by Application (2021-2032) Figure 39. North America β-Nicotinamide Mononucleotide (NMN) Revenue Share by Country (2021-2032) Figure 40. North America β-Nicotinamide Mononucleotide (NMN) Sales Share by Country (2021-2032) Figure 41. Europe β-Nicotinamide Mononucleotide (NMN) Revenue Share by Content (2021-2032) Figure 42. Europe β-Nicotinamide Mononucleotide (NMN) Sales Share by Content (2021-2032) Figure 43. Europe β-Nicotinamide Mononucleotide (NMN) Revenue Share by Application (2021-2032) Figure 44. Europe β-Nicotinamide Mononucleotide (NMN) Sales Share by Application (2021-2032) Figure 45. Europe β-Nicotinamide Mononucleotide (NMN) Revenue Share by Country (2021-2032) Figure 46. Europe β-Nicotinamide Mononucleotide (NMN) Sales Share by Country (2021-2032) Figure 47. China β-Nicotinamide Mononucleotide (NMN) Revenue Share by Content (2021-2032) Figure 48. China β-Nicotinamide Mononucleotide (NMN) Sales Share by Content (2021-2032) Figure 49. China β-Nicotinamide Mononucleotide (NMN) Revenue Share by Application (2021-2032) Figure 50. China β-Nicotinamide Mononucleotide (NMN) Sales Share by Application (2021-2032) Figure 51. Asia β-Nicotinamide Mononucleotide (NMN) Revenue Share by Content (2021-2032) Figure 52. Asia β-Nicotinamide Mononucleotide (NMN) Sales Share by Content (2021-2032) Figure 53. Asia β-Nicotinamide Mononucleotide (NMN) Revenue Share by Application (2021-2032) Figure 54. Asia β-Nicotinamide Mononucleotide (NMN) Sales Share by Application (2021-2032) Figure 55. Asia β-Nicotinamide Mononucleotide (NMN) Revenue Share by Country (2021-2032) Figure 56. Asia β-Nicotinamide Mononucleotide (NMN) Sales Share by Country (2021-2032) Figure 57. SAMEA β-Nicotinamide Mononucleotide (NMN) Revenue Share by Content (2021-2032) Figure 58. SAMEA β-Nicotinamide Mononucleotide (NMN) Sales Share by Content (2021-2032) Figure 59. SAMEA β-Nicotinamide Mononucleotide (NMN) Revenue Share by Application (2021-2032) Figure 60. SAMEA β-Nicotinamide Mononucleotide (NMN) Sales Share by Application (2021-2032) Figure 61. SAMEA β-Nicotinamide Mononucleotide (NMN) Revenue Share by Country (2021-2032) Figure 62. SAMEA β-Nicotinamide Mononucleotide (NMN) Sales Share by Country (2021-2032) Figure 63. β-Nicotinamide Mononucleotide (NMN) Value Chain Figure 64. Manufacturing Cost Structure Figure 65. β-Nicotinamide Mononucleotide (NMN) Production Mode & Process Figure 66. Direct Comparison with Distribution Share Figure 67. Distributors Profiles Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Above 98%
  • Below 98%
Applications
  • Health Care Products
  • Cosmetics
  • Others
Companies covered
  • GeneHarbor
  • Herbalmax
  • Genex Formulas
  • Shinkowa Pharmaceutical
  • Maac10 Formulas
  • EffePharm
  • Bontac
  • CELFULL
  • Kingdomway

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 β-Nicotinamide Mononucleotide (NMN) Market by Content
  3. 1.2.1 Global β-Nicotinamide Mononucleotide (NMN) Market Size by Content, 2021 VS 2025 VS 2032
  4. 1.2.2 Above 98%
  5. 1.2.3 Below 98%
  6. 1.3 β-Nicotinamide Mononucleotide (NMN) Market by Application
  7. 1.3.1 Global β-Nicotinamide Mononucleotide (NMN) Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Health Care Products
  9. 1.3.3 Cosmetics
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 β-Nicotinamide Mononucleotide (NMN) Market Dynamics
  1. 2.1 β-Nicotinamide Mononucleotide (NMN) Industry Trends
  2. 2.2 β-Nicotinamide Mononucleotide (NMN) Industry Drivers
  3. 2.3 β-Nicotinamide Mononucleotide (NMN) Industry Opportunities and Challenges
  4. 2.4 β-Nicotinamide Mononucleotide (NMN) Industry Restraints
3 Global β-Nicotinamide Mononucleotide (NMN) Production Overview
  1. 3.1 Global β-Nicotinamide Mononucleotide (NMN) Production Capacity (2021-2032)
  2. 3.2 Global β-Nicotinamide Mononucleotide (NMN) Production by Region: 2021 VS 2025 VS 2032
  3. 3.3 Global β-Nicotinamide Mononucleotide (NMN) Production by Region
  4. 3.3.1 Global β-Nicotinamide Mononucleotide (NMN) Production by Region (2021-2026)
  5. 3.3.2 Global β-Nicotinamide Mononucleotide (NMN) Production by Region (2027-2032)
  6. 3.3.3 Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Region (2021-2032)
  7. 3.4 North America
  8. 3.5 Europe
  9. 3.6 China
  10. 3.7 Japan
4 Global Market Growth Prospects
  1. 4.1 Global β-Nicotinamide Mononucleotide (NMN) Revenue Estimates and Forecasts (2021-2032)
  2. 4.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Region
  3. 4.2.1 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Region: 2021 VS 2025 VS 2032
  4. 4.2.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2021-2026)
  5. 4.2.3 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2027-2032)
  6. 4.2.4 Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2021-2032)
  7. 4.3 Global β-Nicotinamide Mononucleotide (NMN) Sales Estimates and Forecasts 2021-2032
  8. 4.4 Global β-Nicotinamide Mononucleotide (NMN) Sales by Region
  9. 4.4.1 Global β-Nicotinamide Mononucleotide (NMN) Sales by Region: 2021 VS 2025 VS 2032
  10. 4.4.2 Global β-Nicotinamide Mononucleotide (NMN) Sales by Region (2021-2026)
  11. 4.4.3 Global β-Nicotinamide Mononucleotide (NMN) Sales by Region (2027-2032)
  12. 4.4.4 Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2021-2032)
  13. 4.5 North America
  14. 4.6 Europe
  15. 4.7 China
  16. 4.8 Asia (Excluding China)
  17. 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
  1. 5.1 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Manufacturers
  2. 5.1.1 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Manufacturers (2021-2026)
  3. 5.1.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Manufacturers (2021-2026)
  4. 5.1.3 Global β-Nicotinamide Mononucleotide (NMN) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 5.2 Global β-Nicotinamide Mononucleotide (NMN) Sales by Manufacturers
  6. 5.2.1 Global β-Nicotinamide Mononucleotide (NMN) Sales by Manufacturers (2021-2026)
  7. 5.2.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Manufacturers (2021-2026)
  8. 5.2.3 Global β-Nicotinamide Mononucleotide (NMN) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 5.3 Global β-Nicotinamide Mononucleotide (NMN) Sales Price by Manufacturers (2021-2026)
  10. 5.4 Global β-Nicotinamide Mononucleotide (NMN) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 5.5 Global β-Nicotinamide Mononucleotide (NMN) Key Manufacturers Manufacturing Sites & Headquarters
  12. 5.6 Global β-Nicotinamide Mononucleotide (NMN) Manufacturers, Product Type & Application
  13. 5.7 Global β-Nicotinamide Mononucleotide (NMN) Manufacturers Commercialization Time
  14. 5.8 Market Competitive Analysis
  15. 5.8.1 Global β-Nicotinamide Mononucleotide (NMN) Market CR5 and HHI
  16. 5.8.2 2025 β-Nicotinamide Mononucleotide (NMN) Tier 1, Tier 2, and Tier 3
6 β-Nicotinamide Mononucleotide (NMN) Market by Content
  1. 6.1 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Content
  2. 6.1.1 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2021-2032) & (US$ Million)
  3. 6.1.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Content (2021-2032)
  4. 6.2 Global β-Nicotinamide Mononucleotide (NMN) Sales by Content
  5. 6.2.1 Global β-Nicotinamide Mononucleotide (NMN) Sales by Content (2021-2032) & (Kg)
  6. 6.2.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Content (2021-2032)
  7. 6.3 Global β-Nicotinamide Mononucleotide (NMN) Price by Content
7 β-Nicotinamide Mononucleotide (NMN) Market by Application
  1. 7.1 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Application
  2. 7.1.1 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2032) & (US$ Million)
  3. 7.1.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2021-2032)
  4. 7.2 Global β-Nicotinamide Mononucleotide (NMN) Sales by Application
  5. 7.2.1 Global β-Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2032) & (Kg)
  6. 7.2.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2021-2032)
  7. 7.3 Global β-Nicotinamide Mononucleotide (NMN) Price by Application
8 Company Profiles
  1. 8.1 GeneHarbor
  2. 8.1.1 GeneHarbor Company Information
  3. 8.1.2 GeneHarbor Business Overview
  4. 8.1.3 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 8.1.4 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Product Portfolio
  6. 8.1.5 GeneHarbor Recent Developments
  7. 8.2 Herbalmax
  8. 8.2.1 Herbalmax Company Information
  9. 8.2.2 Herbalmax Business Overview
  10. 8.2.3 Herbalmax β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 8.2.4 Herbalmax β-Nicotinamide Mononucleotide (NMN) Product Portfolio
  12. 8.2.5 Herbalmax Recent Developments
  13. 8.3 Genex Formulas
  14. 8.3.1 Genex Formulas Company Information
  15. 8.3.2 Genex Formulas Business Overview
  16. 8.3.3 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 8.3.4 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Product Portfolio
  18. 8.3.5 Genex Formulas Recent Developments
  19. 8.4 Shinkowa Pharmaceutical
  20. 8.4.1 Shinkowa Pharmaceutical Company Information
  21. 8.4.2 Shinkowa Pharmaceutical Business Overview
  22. 8.4.3 Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 8.4.4 Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Product Portfolio
  24. 8.4.5 Shinkowa Pharmaceutical Recent Developments
  25. 8.5 Maac10 Formulas
  26. 8.5.1 Maac10 Formulas Company Information
  27. 8.5.2 Maac10 Formulas Business Overview
  28. 8.5.3 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 8.5.4 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Product Portfolio
  30. 8.5.5 Maac10 Formulas Recent Developments
  31. 8.6 EffePharm
  32. 8.6.1 EffePharm Company Information
  33. 8.6.2 EffePharm Business Overview
  34. 8.6.3 EffePharm β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 8.6.4 EffePharm β-Nicotinamide Mononucleotide (NMN) Product Portfolio
  36. 8.6.5 EffePharm Recent Developments
  37. 8.7 Bontac
  38. 8.7.1 Bontac Company Information
  39. 8.7.2 Bontac Business Overview
  40. 8.7.3 Bontac β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 8.7.4 Bontac β-Nicotinamide Mononucleotide (NMN) Product Portfolio
  42. 8.7.5 Bontac Recent Developments
  43. 8.8 CELFULL
  44. 8.8.1 CELFULL Company Information
  45. 8.8.2 CELFULL Business Overview
  46. 8.8.3 CELFULL β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 8.8.4 CELFULL β-Nicotinamide Mononucleotide (NMN) Product Portfolio
  48. 8.8.5 CELFULL Recent Developments
  49. 8.9 Kingdomway
  50. 8.9.1 Kingdomway Company Information
  51. 8.9.2 Kingdomway Business Overview
  52. 8.9.3 Kingdomway β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 8.9.4 Kingdomway β-Nicotinamide Mononucleotide (NMN) Product Portfolio
  54. 8.9.5 Kingdomway Recent Developments
9 North America
  1. 9.1 North America β-Nicotinamide Mononucleotide (NMN) Market Size by Content
  2. 9.1.1 North America β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2021-2032)
  3. 9.1.2 North America β-Nicotinamide Mononucleotide (NMN) Sales by Content (2021-2032)
  4. 9.1.3 North America β-Nicotinamide Mononucleotide (NMN) Price by Content (2021-2032)
  5. 9.2 North America β-Nicotinamide Mononucleotide (NMN) Market Size by Application
  6. 9.2.1 North America β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2032)
  7. 9.2.2 North America β-Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2032)
  8. 9.2.3 North America β-Nicotinamide Mononucleotide (NMN) Price by Application (2021-2032)
  9. 9.3 North America β-Nicotinamide Mononucleotide (NMN) Market Size by Country
  10. 9.3.1 North America β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 North America β-Nicotinamide Mononucleotide (NMN) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 North America β-Nicotinamide Mononucleotide (NMN) Price by Country (2021-2032)
  13. 9.3.4 United States
  14. 9.3.5 Canada
  15. 9.3.6 Mexico
10 Europe
  1. 10.1 Europe β-Nicotinamide Mononucleotide (NMN) Market Size by Content
  2. 10.1.1 Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2021-2032)
  3. 10.1.2 Europe β-Nicotinamide Mononucleotide (NMN) Sales by Content (2021-2032)
  4. 10.1.3 Europe β-Nicotinamide Mononucleotide (NMN) Price by Content (2021-2032)
  5. 10.2 Europe β-Nicotinamide Mononucleotide (NMN) Market Size by Application
  6. 10.2.1 Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2032)
  7. 10.2.2 Europe β-Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2032)
  8. 10.2.3 Europe β-Nicotinamide Mononucleotide (NMN) Price by Application (2021-2032)
  9. 10.3 Europe β-Nicotinamide Mononucleotide (NMN) Market Size by Country
  10. 10.3.1 Europe β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 10.3.2 Europe β-Nicotinamide Mononucleotide (NMN) Sales by Country (2021 VS 2025 VS 2032)
  12. 10.3.3 Europe β-Nicotinamide Mononucleotide (NMN) Price by Country (2021-2032)
  13. 10.3.4 Germany
  14. 10.3.5 France
  15. 10.3.6 U.K.
  16. 10.3.7 Italy
  17. 10.3.8 Russia
  18. 10.3.9 Spain
  19. 10.3.10 Netherlands
  20. 10.3.11 Switzerland
  21. 10.3.12 Sweden
11 China
  1. 11.1 China β-Nicotinamide Mononucleotide (NMN) Market Size by Content
  2. 11.1.1 China β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2021-2032)
  3. 11.1.2 China β-Nicotinamide Mononucleotide (NMN) Sales by Content (2021-2032)
  4. 11.1.3 China β-Nicotinamide Mononucleotide (NMN) Price by Content (2021-2032)
  5. 11.2 China β-Nicotinamide Mononucleotide (NMN) Market Size by Application
  6. 11.2.1 China β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2032)
  7. 11.2.2 China β-Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2032)
  8. 11.2.3 China β-Nicotinamide Mononucleotide (NMN) Price by Application (2021-2032)
12 Asia (Excluding China)
  1. 12.1 Asia β-Nicotinamide Mononucleotide (NMN) Market Size by Content
  2. 12.1.1 Asia β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2021-2032)
  3. 12.1.2 Asia β-Nicotinamide Mononucleotide (NMN) Sales by Content (2021-2032)
  4. 12.1.3 Asia β-Nicotinamide Mononucleotide (NMN) Price by Content (2021-2032)
  5. 12.2 Asia β-Nicotinamide Mononucleotide (NMN) Market Size by Application
  6. 12.2.1 Asia β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2032)
  7. 12.2.2 Asia β-Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2032)
  8. 12.2.3 Asia β-Nicotinamide Mononucleotide (NMN) Price by Application (2021-2032)
  9. 12.3 Asia β-Nicotinamide Mononucleotide (NMN) Market Size by Country
  10. 12.3.1 Asia β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 Asia β-Nicotinamide Mononucleotide (NMN) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 Asia β-Nicotinamide Mononucleotide (NMN) Price by Country (2021-2032)
  13. 12.3.4 Japan
  14. 12.3.5 South Korea
  15. 12.3.6 India
  16. 12.3.7 Australia
  17. 12.3.8 Taiwan
  18. 12.3.9 Southeast Asia
13 South America, Middle East and Africa
  1. 13.1 SAMEA β-Nicotinamide Mononucleotide (NMN) Market Size by Content
  2. 13.1.1 SAMEA β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2021-2032)
  3. 13.1.2 SAMEA β-Nicotinamide Mononucleotide (NMN) Sales by Content (2021-2032)
  4. 13.1.3 SAMEA β-Nicotinamide Mononucleotide (NMN) Price by Content (2021-2032)
  5. 13.2 SAMEA β-Nicotinamide Mononucleotide (NMN) Market Size by Application
  6. 13.2.1 SAMEA β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2032)
  7. 13.2.2 SAMEA β-Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2032)
  8. 13.2.3 SAMEA β-Nicotinamide Mononucleotide (NMN) Price by Application (2021-2032)
  9. 13.3 SAMEA β-Nicotinamide Mononucleotide (NMN) Market Size by Country
  10. 13.3.1 SAMEA β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 13.3.2 SAMEA β-Nicotinamide Mononucleotide (NMN) Sales by Country (2021 VS 2025 VS 2032)
  12. 13.3.3 SAMEA β-Nicotinamide Mononucleotide (NMN) Price by Country (2021-2032)
  13. 13.3.4 Brazil
  14. 13.3.5 Argentina
  15. 13.3.6 Chile
  16. 13.3.7 Colombia
  17. 13.3.8 Peru
  18. 13.3.9 Saudi Arabia
  19. 13.3.10 Israel
  20. 13.3.11 UAE
  21. 13.3.12 Turkey
  22. 13.3.13 Iran
  23. 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
  1. 14.1 β-Nicotinamide Mononucleotide (NMN) Value Chain Analysis
  2. 14.1.1 β-Nicotinamide Mononucleotide (NMN) Key Raw Materials
  3. 14.1.2 Raw Materials Key Suppliers
  4. 14.1.3 Manufacturing Cost Structure
  5. 14.1.4 β-Nicotinamide Mononucleotide (NMN) Production Mode & Process
  6. 14.2 β-Nicotinamide Mononucleotide (NMN) Sales Channels Analysis
  7. 14.2.1 Direct Comparison with Distribution Share
  8. 14.2.2 β-Nicotinamide Mononucleotide (NMN) Distributors
  9. 14.2.3 β-Nicotinamide Mononucleotide (NMN) Customers
15 Concluding Insights
    16 Appendix
    1. 16.1 Reasons for Doing This Study
    2. 16.2 Research Methodology
    3. 16.3 Research Process
    4. 16.4 Authors List of This Report
    5. 16.5 Data Source
    6. 16.5.1 Secondary Sources
    7. 16.5.2 Primary Sources
    8. 16.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst